In obesity, low SHBG is implicated in increasing insulin resistance and cardiovascular risk and is suggested to be a marker of abdominal obesity (Brand et al., 2014; Gyawali et al., 2018; Moon et al., 2017; Perry et al., 2010; Wang et al., 2015). Here, SHBG is linked to obesity disorder.